Provided by Tiger Trade Technology Pte. Ltd.

Esperion Therapeutics

2.77
-0.0850-2.98%
Volume:1.55M
Turnover:4.31M
Market Cap:710.08M
PE:-25.34
High:2.84
Open:2.82
Low:2.75
Close:2.85
52wk High:4.18
52wk Low:0.6925
Shares:256.81M
Float Shares:237.00M
Volume Ratio:0.36
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1091
EPS(LYR):-0.1091
ROE:97.76%
ROA:9.30%
PB:-2.35
PE(LYR):-25.34

Loading ...

Esperion Announces New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) in Oral and Poster Presentations at the AHA Scientific Sessions 2025

GlobeNewswire
·
Nov 10, 2025

Esperion Therapeutics Grants 77,650 RSUs to New Employees Under Inducement Plan

Reuters
·
Nov 07, 2025

Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Nov 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 07, 2025

Esperion Q3 revenue up 69% on prescription volumes

Reuters
·
Nov 06, 2025

Stock Track | Esperion Therapeutics Plunges 6.12% Pre-market on Disappointing Q3 Earnings

Stock Track
·
Nov 06, 2025

Stock Track | Esperion Therapeutics Plunges 6.12% Pre-Market on Disappointing Q3 Earnings

Stock Track
·
Nov 06, 2025

Esperion Therapeutics Q3 EPS $(0.16) Misses $(0.08) Estimate, Sales $87.309M Beat $77.803M Estimate

Benzinga
·
Nov 06, 2025

Esperion Reiterates 2025 Operating Expense Guidance at $215–$235 Million

Reuters
·
Nov 06, 2025

BRIEF-Esperion Therapeutics Q3 Product Sales USD 40.659 Million

Reuters
·
Nov 06, 2025

Esperion Therapeutics Inc Reiterates Its Expectation for Full Year 2025 Operating Expenses to Be in the Range of $215 Million to $235 Million

THOMSON REUTERS
·
Nov 06, 2025

Esperion Therapeutics Expects to Achieve Sustainable Profitability Beginning in the First Quarter of 2026

THOMSON REUTERS
·
Nov 06, 2025

Esperion Therapeutics Appoints John Harlow as Chief Commercial Officer

Reuters
·
Nov 04, 2025

Press Release: Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

Dow Jones
·
Nov 04, 2025

Esperion to Participate in Jefferies Global Healthcare Conference - London

GlobeNewswire
·
Nov 03, 2025

GS1 Hong Kong Equips Local Businesses to Turn EU's Digital Product Passport Mandate into a Competitive Edge

prnewswire
·
Oct 31, 2025

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.

GlobeNewswire
·
Oct 28, 2025

Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025

GlobeNewswire
·
Oct 27, 2025

Esperion to Report Third Quarter 2025 Financial Results on November 6

GlobeNewswire
·
Oct 23, 2025

Esperion (ESPR) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Oct 17, 2025